
Tuesday Jul 09, 2024
INVOS™ technology overview pt 7: How is the algorithm developed for the pediatric population?
Eli Kuhlmann, Sr. Research Manager at Medtronic, describes how the INVOS™ system pediatric algorithm was developed in order to account for factors impacting regional oximetry measurements in pediatric patients. The INVOS™ monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.
No comments yet. Be the first to say something!